BT
Blaine Templeman
Chief Legal Officer

Blaine Templeman insider trades: Aduro Biotech (ADRO) stock sales

Chief Legal Officer, Aduro Biotech Last trade Sep 15, 2020 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2017
1
Company
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Blaine reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 15, 2020ADRO↓ Sell$30K
Aug 7, 2020ADRO↓ Sell$20K
Dec 12, 2019ADRO↓ Sell$1K
Sep 13, 2019ADRO↓ Sell$17K
Dec 12, 2018ADRO↓ Sell$4K
Nov 20, 2018ADRO↓ Sell$2K
Sep 24, 2018ADRO↓ Sell$60K
Sep 13, 2018ADRO↓ Sell$39K
May 17, 2018ADRO↓ Sell$16K
Dec 18, 2017ADRO↓ Sell$24K
Nov 17, 2017ADRO↓ Sell$2K
Sep 18, 2017ADRO↓ Sell$32K
Sep 13, 2017ADRO↓ Sell$39K
May 17, 2017ADRO↓ Sell$16K
Jan 11, 2017ADRO↓ Sell$45K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Blaine Templeman's insider trades

Blaine Templeman is Chief Legal Officer at Aduro Biotech (ADRO). Since Jan 11, 2017, Blaine has reported no open-market purchases and 15 sales worth $348K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.